Andrea Smith in Missoula, Montana

Medical School: University Of Colorado School Of Medicine, Denver
Graduation Year: 2013
The Primary Medical Specialty for Andrea Smith is listed as: Internal Medicine
Approximate Years of Experience: 12
PAC (PECOS ID)#: 2860621620
NPI #: 1760825533
NPI Created On: 04/11/2013
NPI Last Updated Listed as: 04/02/2021
Primary Taxonomy Code: 207R00000X
License Number:
0101261098
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Montana Health Cooperative
• PacificSource Health Plans
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Removal of impact ear wax, one ear
2. Vaccine for influenza for injection into muscle
3. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
4. Routine ekg using at least 12 leads including interpretation and report
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. New patient office or other outpatient visit, typically 45 minutes
7. Established patient office or other outpatient visit, typically 15 minutes
8. Established patient office or other outpatient, visit typically 25 minutes
9. Physician telephone patient service, 5-10 minutes of medical discussion
10. Physician telephone patient service, 11-20 minutes of medical discussion
11. Physician telephone patient service, 21-30 minutes of medical discussion
12. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
13. Administration of influenza virus vaccine
14. Administration of pneumococcal vaccine
15. Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
16. Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
17. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
18. Injection, denosumab, 1 mg